Changeflow GovPing Healthcare & Life Sciences Nelkarmi Pharmaceutical Trademark - Oncology
Routine Notice Added Final

Nelkarmi Pharmaceutical Trademark - Oncology

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

USPTO received trademark application TM99192492 for 'NELKARMI' covering pharmaceutical preparations for oncology diseases and disorders on May 19, 2025. The application was filed under Intent-to-Use provisions with a deadline of March 31, 2026 for the Statement of Use.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO filed trademark application TM99192492 for 'NELKARMI' on May 19, 2025. The trademark covers pharmaceutical preparations and products for use in oncology diseases and disorders. The application is filed under Intent-to-Use basis, requiring the applicant to demonstrate actual commercial use of the mark within three years of publication.

No immediate action is required from competitors or industry participants. Trademark applications are public record and available for opposition proceedings. Companies developing similar oncology pharmaceutical products may wish to review the application for potential conflicts with existing or planned trademarks. The Intent-to-Use deadline of March 31, 2026 applies to the applicant only.

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

NELKARMI

Intent to Use TM99192492 Kind: intenttouse Mar 31, 2026

Abstract

Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders

Filing Date

2025-05-19

View original document →

Named provisions

Intent to Use Provision

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
May 19th, 2025
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
TM99192492

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology 6211 Healthcare Providers
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!